3950 South Country Club Road
Suite 470 4th Floor
Tucson, AZ 85714
United States
520 365 3100
https://acceleratediagnostics.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 134
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Jack Phillips | CEO, President & Director | 595k | N/D | 1966 |
Ms. Maya Gowri | Senior VP & Head of Operations | N/D | N/D | N/D |
Laura Pierson | Investor Relations Officer | N/D | N/D | N/D |
Mr. John Meduri | Chief Strategy Officer | N/D | N/D | N/D |
Mr. Chris Thode | Senior Vice President of US Commercial | N/D | N/D | N/D |
Ms. Rita Boukamel | Senior VP & Head of EMEA | N/D | N/D | N/D |
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.
La calificación ISS Governance QuickScore de Accelerate Diagnostics, Inc. a partir del 1 de abril de 2024 es 6. Las puntuaciones principales son Auditoría: 10; Junta: 3; Derechos del accionista: 3; Compensación: 8.